Approval For Phase III study of New Antibiotics
16345
news-template-default,single,single-news,postid-16345,bridge-core-1.0.4,ajax_fade,page_not_loaded,,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.0.9,qode-theme-bridge,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-5.7,vc_responsive
 

Approval For Phase III study of New Antibiotics

Home > Approval For Phase III study of New Antibiotics

28 Sep Approval For Phase III study of New Antibiotics

Posted at 08:11h in by

Excited to share news that a study that we designed and presented to the Subject Expert Committee (SEC), received clearance from the DCGI office today. This Phase 3 study will help to develop new antibiotic to treat serious bacterial diseases in patients with unmet medical need.

1 Comment

Post A Comment